Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beat Neuenschwander

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Pharmaceutical Statistics|December 20, 2015
Robust exchangeability designs for early phase clinical trials with multiple strataBeat Neuenschwander, Simon Wandel, Satrajit Roychoudhury, et al.
Biometrics|April 7, 2020
Rejoinder to "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'HaganBeat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Biometrics|March 7, 2020
Predictively consistent prior effective sample sizesBeat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Statistics in Medicine|June 1, 2013
Using historical control information for the design and analysis of clinical trials with overdispersed count dataSandro Gsteiger, Beat Neuenschwander, Francois Mercier, et al.
Clinical Trials (London, England)|April 8, 2017
Using phase II data for the analysis of phase III studies: An application in rare diseasesSimon Wandel, Beat Neuenschwander, Christian Röver, et al.
Materials (Basel, Switzerland)|July 2, 2021
Review on Experimental and Theoretical Investigations of Ultra-Short Pulsed Laser Ablation of Metals with Burst PulsesDaniel J Förster, Beat Jäggi, Andreas Michalowski, et al.
Therapeutic Innovation & Regulatory Science|March 16, 2022
The Predictive Individual Effect for Survival DataBeat Neuenschwander, Satrajit Roychoudhury, Simon Wandel, et al.
Clinical Trials (London, England)|February 17, 2010
Summarizing historical information on controls in clinical trialsBeat Neuenschwander, Gorana Capkun-Niggli, Michael Branson, et al.
Statistics in Medicine|February 26, 2011
A proof of concept phase II non-inferiority criterionBeat Neuenschwander, Nicolas Rouyrre, Norbert Hollaender, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2009
Combining MCMC with 'sequential' PKPD modellingDavid Lunn, Nicky Best, David Spiegelhalter, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Pharmaceutical Statistics|December 20, 2015
Robust exchangeability designs for early phase clinical trials with multiple strataBeat Neuenschwander, Simon Wandel, Satrajit Roychoudhury, et al.
Biometrics|April 7, 2020
Rejoinder to "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'HaganBeat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Biometrics|March 7, 2020
Predictively consistent prior effective sample sizesBeat Neuenschwander, Sebastian Weber, Heinz Schmidli, et al.
Statistics in Medicine|June 1, 2013
Using historical control information for the design and analysis of clinical trials with overdispersed count dataSandro Gsteiger, Beat Neuenschwander, Francois Mercier, et al.
Clinical Trials (London, England)|April 8, 2017
Using phase II data for the analysis of phase III studies: An application in rare diseasesSimon Wandel, Beat Neuenschwander, Christian Röver, et al.
Materials (Basel, Switzerland)|July 2, 2021
Review on Experimental and Theoretical Investigations of Ultra-Short Pulsed Laser Ablation of Metals with Burst PulsesDaniel J Förster, Beat Jäggi, Andreas Michalowski, et al.
Therapeutic Innovation & Regulatory Science|March 16, 2022
The Predictive Individual Effect for Survival DataBeat Neuenschwander, Satrajit Roychoudhury, Simon Wandel, et al.
Clinical Trials (London, England)|February 17, 2010
Summarizing historical information on controls in clinical trialsBeat Neuenschwander, Gorana Capkun-Niggli, Michael Branson, et al.
Statistics in Medicine|February 26, 2011
A proof of concept phase II non-inferiority criterionBeat Neuenschwander, Nicolas Rouyrre, Norbert Hollaender, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2009
Combining MCMC with 'sequential' PKPD modellingDavid Lunn, Nicky Best, David Spiegelhalter, et al.
Pageof 3